Biologics for Stricturing Crohn's Diseases

Last updated: May 10, 2023
Sponsor: Jinling Hospital, China
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

treat these patients with biologics

Clinical Study ID

NCT05645055
JinlingH20221203
  • Ages 16-65
  • All Genders

Study Summary

Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients with stricturing Crohn's diseases
  • no surgical indication
  • patients with asymptomatic penetrating diseases
  • written consent acquired

Exclusion

Exclusion Criteria:

  • patients with surgical indication
  • patients with symptomatic penetrating diseases
  • contraindication of biologics
  • anticipating other trial

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: treat these patients with biologics
Phase:
Study Start date:
January 01, 2021
Estimated Completion Date:
January 31, 2029

Connect with a study center

  • Department of General Surgery, Jinling hosptal,Medical School of Nanjing University

    Nanjing, Jiangsu 210002
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.